BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cochlear Americas Release: the Cochlear™ Baha® System Continues to Shape the Future of Bone Conduction Implant Technology


11/20/2012 8:46:39 AM

CENTENNIAL, Colo., Nov. 19, 2012 /PRNewswire/ -- Cochlear Americas announced today the introduction of the Cochlear Baha BIA400 series, which features a unique abutment surface technology a hydroxyapatite layer that enables a tight adherence between the soft tissue and the abutment. This technology is designed to minimize the need for soft tissue removal and simplify the surgical procedure.

Important benefits for patients are that the surgical procedure becomes less invasive and the soft tissue disruption can be minimized. This new technology is designed to provide bone conduction patients with better aesthetic outcomes than with conventional percutaneous abutments. Leaving the soft tissue intact may also result in significantly shorter surgery time, faster healing and increase the likelihood of normal post-operative skin sensation around the implant site.

"As the first bone conduction implant company, we continue to innovate our solutions to better meet the needs of our recipients. We see the introduction of the BIA400 as a natural step in our continuous effort to improve the outcomes for our users," said Anthony Manna, President of Cochlear Bone Anchored Solutions.

The Cochlear Baha BA400 Abutment was recently cleared for use in the United States and Canada by the US Food and Drug Administration (FDA) and Health Canada, respectively. The BIA400 series is currently being introduced to these markets through a controlled market release, and is expected to be widely available to clinicians in early 2013.

About Bone Anchored Hearing Solutions
Bone-anchored hearing solutions are a proven medical option for adults and children with conductive hearing loss, mixed hearing loss, and single-sided sensorineural deafness meeting the candidacy criteria. The Baha System sends external sounds to the inner ear through the bone, bypassing the outer and middle ear. Bone anchored hearing solutions are designed to provide audibility and to improve the communication abilities of those who receive little or no benefit from hearing aids.

About Cochlear
Cochlear is the world leader in advanced hearing technologies. Since launching the first multichannel cochlear implant system 30 years ago, Cochlear Limited and its U.S. headquarters have brought the miracle of sound to more than 250,000 people with hearing loss across the globe. For more information about Cochlear Americas products, please visit www.cochlearamericas.com.

SOURCE Cochlear Americas



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES